<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03191110</url>
  </required_header>
  <id_info>
    <org_study_id>NL30446.091.09</org_study_id>
    <secondary_id>CMO number 2009/349</secondary_id>
    <nct_id>NCT03191110</nct_id>
  </id_info>
  <brief_title>The COLON Study: Colorectal Cancer Cohort</brief_title>
  <acronym>COLON</acronym>
  <official_title>The COLON Study: Colorectal Cancer: Longitudinal, Observational Study on Nutritional and Lifestyle Factors That May Influence Colorectal Tumour Recurrence, Survival and Quality of Life</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wageningen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Funding: Alpe D'Huzes / Dutch Cancer Society</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Funding: Wereld Kanker Onderzoek Fonds</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Funding: World Cancer Research Fund International</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Funding: ERA-NET on Translational Cancer Research (TRANSCAN)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Wageningen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main aim of this observational, prospective cohort study is to assess associations of
      diet and other lifestyle factors with colorectal cancer recurrence, survival and quality of
      life.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The COLON study is a multi-centre prospective cohort study among incident colorectal cancer
      patients recruited from 12 hospitals in the Netherlands. Patients with colorectal cancer are
      invited upon diagnosis. Upon recruitment, after 6 months, 2 years and 5 years, patients fill
      out food-frequency questionnaires; questionnaires about dietary supplement use, physical
      activity, weight, height, and quality of life; and donate blood samples. Diagnostic CT-scans
      are collected to assess cross-sectional areas of skeletal muscle, subcutaneous fat, visceral
      fat and intermuscular fat, and to assess muscle attenuation. Blood samples are biobanked to
      facilitate future analyse of biomarkers, nutrients, DNA etc. Analysis of serum 25-hydroxy
      vitamin D levels, B-vitamins and metabolomic profiles are scheduled. A subgroup of patients
      with colon cancer is asked to provide faecal samples before and at several time points after
      colon resection to study changes in gut microbiota during treatment. For all patients,
      information on vital status is retrieved by linkage with national registries. Information on
      clinical characteristics, including treatment-related toxicity and co-morbidity data, is
      gathered from linkage with the Netherlands Cancer Registry and with hospital databases or
      medical records. Hazard ratios will be calculated for dietary and lifestyle factors at
      diagnosis in relation to recurrence and survival. Repeated measures analyses will be
      performed to assess changes over time in dietary and other factors in relation to recurrence
      and survival.

      The aim is to recruit at least 2000 patients with available data and blood samples.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 3, 2010</start_date>
  <primary_completion_date type="Anticipated">December 2030</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Survival</measure>
    <time_frame>An average follow-up of at least 5 years</time_frame>
    <description>Overall survival</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cancer recurrence</measure>
    <time_frame>An average follow-up of at least 5 years</time_frame>
    <description>Cancer recurrence</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of life (EORTC QLQ-C30)</measure>
    <time_frame>An average follow-up of at least 5 years</time_frame>
    <description>Quality of life</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Chemotherapy-induced toxicity (QLQ-CIPN20)</measure>
    <time_frame>12 months after diagnosis</time_frame>
    <description>Chemotherapy-induced peripheral neuropathy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Microbiota composition based on 16S rRNA profiling</measure>
    <time_frame>At diagnosis and 6, 12 and 35 weeks after resection</time_frame>
    <description>Stool samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Co-morbidities</measure>
    <time_frame>An average follow-up of at least 5 years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Colorectal Neoplasms Malignant</condition>
  <arm_group>
    <arm_group_label>Colorectal cancer patients</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention: observational study</intervention_name>
    <arm_group_label>Colorectal cancer patients</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples will be collected for all participants. Stool samples will be collected in a
      subgroup of colon cancer patients.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Men and women of all ages, who were newly diagnosed with colorectal cancer (ICD codes
        C18-20) in any stage of the disease in one of the participating hospitals.
      </textblock>
    </study_pop>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Patients newly diagnosed with colorectal cancer in one of the participating hospitals

        Exclusion Criteria:

          -  Non-Dutch speaking

          -  A history of colorectal cancer or (partial) bowel resection

          -  Chronic inflammatory bowel disease

          -  Hereditary colorectal cancer syndromes (Lynch syndrome, FAP, Peutz-Jegher)

          -  Dementia or another mental condition that makes it impossible to fill out
             questionnaires
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ellen Kampman, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wageningen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dieuwertje Kok, PhD</last_name>
    <phone>+31 317 485 901</phone>
    <email>dieuwertje.kok@wur.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Fr√§nzel van Duijnhoven, PhD</last_name>
    <phone>+31 317 485 375</phone>
    <email>franzel.vanduijnhoven@wur.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ziekenhuisgroep Twente</name>
      <address>
        <city>Almelo</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Gelre Hospital</name>
      <address>
        <city>Apeldoorn</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Rijnstate Hospital</name>
      <address>
        <city>Arnhem</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Slingeland Hospital</name>
      <address>
        <city>Doetinchem</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Gelderse Vallei</name>
      <address>
        <city>Ede</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Admiraal De Ruyter Hospital</name>
      <address>
        <city>Goes/Vlissingen</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Martini Hospital</name>
      <address>
        <city>Groningen</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Canisius Wilhelmina Hospital</name>
      <address>
        <city>Nijmegen</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Radboudumc</name>
      <address>
        <city>Nijmegen</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Bernhoven Hospital</name>
      <address>
        <city>Oss</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Isala Klinieken</name>
      <address>
        <city>Zwolle</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <link>
    <url>http://www.colon-studie.nl/colonstudy_eng</url>
    <description>Website for studies on Diet and Cancer, Division of Human Nutrition, Wageningen University</description>
  </link>
  <reference>
    <citation>Winkels RM, Heine-Br√∂ring RC, van Zutphen M, van Harten-Gerritsen S, Kok DE, van Duijnhoven FJ, Kampman E. The COLON study: Colorectal cancer: Longitudinal, Observational study on Nutritional and lifestyle factors that may influence colorectal tumour recurrence, survival and quality of life. BMC Cancer. 2014 May 27;14:374. doi: 10.1186/1471-2407-14-374.</citation>
    <PMID>24886284</PMID>
  </reference>
  <reference>
    <citation>van Zutphen M, Winkels RM, van Duijnhoven FJ, van Harten-Gerritsen SA, Kok DE, van Duijvendijk P, van Halteren HK, Hansson BM, Kruyt FM, Bilgen EJ, de Wilt JH, Dronkers JJ, Kampman E. An increase in physical activity after colorectal cancer surgery is associated with improved recovery of physical functioning: a prospective cohort study. BMC Cancer. 2017 Jan 25;17(1):74. doi: 10.1186/s12885-017-3066-2.</citation>
    <PMID>28122534</PMID>
  </reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 9, 2017</study_first_submitted>
  <study_first_submitted_qc>June 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 19, 2017</study_first_posted>
  <last_update_submitted>June 15, 2017</last_update_submitted>
  <last_update_submitted_qc>June 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COLON</keyword>
  <keyword>colorectal cancer</keyword>
  <keyword>nutrition</keyword>
  <keyword>lifestyle</keyword>
  <keyword>survival</keyword>
  <keyword>recurrence</keyword>
  <keyword>quality of life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Colonic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

